Banc of California (NYSE:BANC) Rating Lowered to Market Perform at Keefe, Bruyette & Woods theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) issued its quarterly earnings data on Wednesday. The biotechnology company reported ($0.26) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.32) by $0.06, Briefing.com reports. The company had revenue of $47.57 million for the quarter, compared to the consensus estimate of $40.12 million. […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) was the target of unusually large options trading activity on Thursday. Traders purchased 13,731 call options on the stock. This represents an increase of 609% compared to the typical daily volume of 1,937 call options. Pacific Biosciences of California Price Performance PACB stock traded down $0.63 […]
Banc of California, Inc. (NYSE:BANC – Get Rating) saw a significant decline in short interest in May. As of May 31st, there was short interest totalling 1,050,000 shares, a decline of 27.1% from the May 15th total of 1,440,000 shares. Based on an average trading volume of 691,500 shares, the short-interest ratio is currently 1.5 […]
Water Island Capital LLC acquired a new position in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 17,000 shares of the biotechnology company’s stock, valued at approximately $139,000. Other hedge funds have also recently made changes to their positions in the company. Amalgamated Bank […]